CN Patent

CN1856313B — 治疗化合物

Assigned to Cancer Research Technology Ltd · Expires 2011-01-12 · 15y expired

What this patent protects

本发明涉及三环内酰胺吲哚衍生物和三环内酰胺苯并咪唑衍生物及其在抑制PARP酶活性中的应用。本发明还涉及这些化合物在制备药物中的应用。

USPTO Abstract

本发明涉及三环内酰胺吲哚衍生物和三环内酰胺苯并咪唑衍生物及其在抑制PARP酶活性中的应用。本发明还涉及这些化合物在制备药物中的应用。

Drugs covered by this patent

rucaparib-camsylate (RUCAPARIB CAMSYLATE)

Patent Metadata

Patent number: CN1856313B
Jurisdiction: CN
Classification: —
Expires: 2011-01-12
Drug substance claim: No
Drug product claim: No
Assignee: Cancer Research Technology Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.